Skip to main content

FLT3

  • Living reference work entry
  • First Online:
Encyclopedia of Cancer
  • 38 Accesses

Synonyms

Cluster of differentiation antigen 135 (CD135); Fetal liver kinase-2 (FLK2); Fms-like tyrosine-kinase 3; Human stem cell kinase-1 (STK1)

Definition

FLT3 is an important cell surface marker expressed in certain types of hematopoietic progenitors in the bone marrow. Multipotent progenitors and common lymphoid progenitors express high surface levels of FLT3.

Characteristics

FLT3 was originally isolated as a hematopoietic progenitor cell-specific kinase and belongs to the class III receptor tyrosine-kinase (RTK) family, which also includes c-Fms, c-Kit, and platelet-derived growth factor receptor (PDGFR). FLT3 contains five extracellular immunoglobulin-like domains, a transmembrane domain, a juxtamembrane domain, and two tyrosine-kinase domains that are linked through tyrosine-kinase insert. Cytoplasmic FLT3 undergoes glycosylation, which promotes localization of the receptor to the membrane. Signaling through FLT3 plays a role in cell survival, proliferation, and differentiation....

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tao Liu .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Liu, T. (2014). FLT3. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_7075-5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27841-9_7075-5

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27841-9

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics